| 引用本文:郑东海，董文杰，郑伟鸿，指导：郑伟达.慈丹胶囊治疗原发性肝癌Ⅳ期86例的临床研究[J].世界中医药,2012,7(2):. |
|
| 慈丹胶囊治疗原发性肝癌Ⅳ期86例的临床研究 |
| Clinical Observation of Effect of Ci Dan Capsule on 63 Patients of Primary Liver Carcinoma of phaseⅣ |
| 投稿时间：2012-03-01 |
| DOI： |
| 中文关键词: 原发性肝癌Ⅳ期/中医药疗法 慈丹胶囊 |
| English Keywords:Primary liver carcinoma of phaseⅣ/ Chinese medical therapy Ci Dan Capsule |
| 基金项目: |
|
| 摘要点击次数: 1320 |
| 全文下载次数: 1387 |
| 中文摘要: |
| 目的：观察慈丹胶囊治疗原发性肝癌Ⅳ期的疗效及安全性。方法：采用开放随机分组的方法，将160例原发性肝癌患者随机分为2组。治疗组86例，给予慈丹胶囊5粒/次，每日4次。对照组74例，给予慈丹胶囊治疗的同时，加服化疗药。1个月为1个疗程，3个疗程后，评估慈丹胶囊治疗原发性肝癌的疗效与安全性。结果：对照组各瘤体观察疗效、分期与疗效方面优于治疗组，肝肾功能、血象变化、不良反应方面治疗组优于对照组。结论：慈丹胶囊治疗原发性肝癌安全有效。 |
| English Summary: |
| To explore efficacy and safety of Ci Dan capsule for treatment of primary liver carcinoma of phaseⅣ.Methods:Patients of primary liver carcinoma of phaseⅣ (n=160) were open randomized to treatment group (n=86), to take Ci Dan capsules, 5 capsules each time, 4 times daily, and control group ( n=74) to take Ci Dan capsules on top of chemotherapy. After 3 courses of treatment (3 months), efficacy and safety of Ci Dan capsule were evaluated.Results:The control group was better in observed efficacy, phase classification, while the treatment was better liver and kidney functional improvement, hematology parameters and safety.Conclusion:Ci Dan capsule is effective and safe in the treatment of primary liver carcinoma. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
